The implications of heterogeneous DNA methylation for the accurate quantification of methylation DNA methylation has been recognized to play an important role in developmental biology, aging and cancer etiology [1] [2] [3] [4] [5] . Many genes are deregulated by DNA methylation in cancer [6, 7] . Aberrant DNA methylation associated with certain genes has attracted considerable interest as a potential biomarker for the early detection of disease onset, prognosis and choice of treatment, and the monitoring of disease after therapy [8] [9] [10] .
In mammals, DNA methylation occurs principally at CpG dinucleotides. CpG dinucleotides are unevenly distributed throughout the genome and the majority are normally methylated [11] . Some regions of the genome show a high CpG density spanning hundreds to thousands of base pairs, and are termed CpG islands [12] . These CpG islands are often associated with the promoter regions of genes and are then generally unmethylated [13] . If the promoter CpG islands become methylated, either as part of a developmental or pathological process, this leads to the formation of a repressive chromatin complex and the gene is silenced [14] .
Heterogeneous DNA methylation
DNA methylation is usually analyzed in the context of a PCR amplicon generated from bisulfite treated DNA. Each CpG position in each of the template molecules can be either unmethylated or methylated. For the amplicon, fully methylated means that all the tested CpG positions in the amplicon are methylated. Similarly, (fully) unmethylated means that all the CpG positions in the amplicon are unmethylated.
Methylation heterogeneity can arise at several levels. At the simplest level, it has been used to refer to a mixture of fully methylated and unmethylated alleles. A homogeneous mixture of cells may contain both unmethylated and fully methylated alleles, such as is the case for imprinted genes, such as H19 [15] . Alternatively, a heterogeneous mixture of cells may comprise methylated and unmethylated alleles in varying proportions.
In this article, we will reserve the term heterogeneous methylation for the specific context where multiple alleles, which differ in the pattern of methylated and unmethylated CpG sites, are present. The term epialleles can be useful to describe these multiple alleles. Each unique pattern of DNA methylation for a given genomic sequence, including fully methylated and unmethylated, would comprise one of the possible epialleles that can exist in a sample. Figure 1 shows all eight possible epialleles for a region comprising three CpG positions. It should be noted that it is impossible to distinguish the DNA methylation scenarios shown in Figure 1A & 1B by methodologies (e.g., pyrosequencing) that can quantify methylation at individual CpG sites.
DNA methylation based biomarkers have considerable potential for molecular diagnostics, both as tumor specific biomarkers for the early detection or post-therapeutic monitoring of cancer as well as prognostic and predictive biomarkers for therapeutic stratification. Particularly in the former, the accurate estimation of DNA methylation is of compelling importance. However, quantification of DNA methylation has many traps for the unwary, especially when heterogeneous methylation comprising multiple alleles with varied DNA methylation patterns (epialleles) is present. The frequent occurrence of heterogeneous methylation as distinct from a simple mixture of fully methylated and unmethylated alleles is generally not taken into account when DNA methylation is considered as a cancer biomarker. When heterogeneous DNA methylation is present, the proportion of methylated molecules is difficult to quantify without a method that allows the measurement of individual epialleles. In this article, we critically assess the methodologies frequently used to investigate DNA methylation, with an emphasis on the detection and measurement of heterogeneous DNA methylation. The adoption of digital approaches will enable the effective use of heterogeneous DNA methylation as a cancer biomarker.
future science group
If a CpG island becomes aberrantly methylated in cancer, heterogeneous methylation is frequently observed. The evidence for heterogeneous DNA methylation has largely come from bisulfite sequencing of single clones, for example for the DNA repair gene MGMT [16] , the RB1 tumor suppressor gene [17] , the cell cycle progression inhibitor CDKN2B (p15) [18] [19] [20] and the proapoptotic gene DAPK1 [21] . The spectrum of heterogeneous methylation usually varies between different samples. This has recently been illustrated for the CDKN2B (p15) gene, where acute myeloid leukemia (AML) samples are heterogeneously methylated to different extents [22] .
The biology of heterogeneous methylation is incompletely understood. Heterogeneous DNA methylation profiles may result from heterogeneity within a sample [23] . However, it remains unclear whether this heterogeneity derives from multiple independent origins of methylation, a gradual accumulation of changes in DNA methylation during semiconservative replication of the DNA methylation pattern, or whether there is a continual flux of DNA methyl ation patterns within the mitotic progeny of a cell. The DNA methylation level may also increase for some gene loci during aging [24] [25] [26] and tumor progression [27] .
One question that has not yet been resolved is how much DNA methylation is needed for recruitment of the repressive transcriptional machinery? For CDKN2B, a proportion of 30-40% of the potentially methylated CpG sites has been estimated, but the question remains open as this may well depend on the gene and the region of the promoter being examined [19] .
The continually growing interest in investigating DNA methylation has led to the development of multiple approaches to detect DNA methylation at specific gene loci. Furthermore, the increasing use of DNA methylation as a biomarker of disease means that accurate quantification of the fraction of methylated alleles is of compelling importance. It is especially important if DNA methylation is to be used as a biomarker of response to therapy where quantitative estimations are desirable.
Methodology also plays a key role in deciding whether to call a locus methylated. Some loci of clinical importance may show low DNA methylation levels in normal tissues of some individuals, or may be heterogeneously methylated in cancer, or both. For example, methylation of the MGMT locus is an important predictive biomarker when certain alkylating chemo therapeutic drugs are used [28, 29] . However, commonly used methodologies such as methylation-specific PCR (MSP) (reviewed later) are unreliable in the assessment of MGMT promoter methylation [30] . This derives from the heterogeneous methylation that this locus often shows [16] , the low level of DNA methylation in the normal tissues of some individuals [31] and technical issues in the reliable performance of MSP. The region of a CpG island that is tested for DNA methylation may also play a crucial role [32] [33] [34] , highlighting the importance of preliminary work to determine the likelihood of the methylation of particular regions or positions being more important or informative than others [34, 35] .
The ana lysis of DNA methylation has many traps for the unwary. In particular, the impact of methodology in measuring DNA methylation is often ignored. This is largely a consequence of the fact that most assays do not differentiate homogeneous and heterogeneous methylation. Heterogeneous DNA methylation Review
In this article, we will assess the problems raised by heterogeneous DNA methylation for methodologies commonly used to investigate methylation at single gene loci. It is of considerable importance to know and understand the limitations of available approaches in order to interpret the data generated from a particular experiment.
Methods
All the methods described in this article use bisulfite-treated DNA as the starting material in PCR reactions. It is common to refer to a PCR product deriving from a single set of primers as an amplicon. In the case of heterogeneous DNA methylation, the PCR product is a complex mixture of many amplicons and heteroduplexes between those amplicons. In the interest of simplicity, however, we will use the word amplicon even when there are obviously many amplicons.
Several technical issues are common to most methods. A poor bisulfite conversion rate will result in an overestimation of the calculated DNA methylation level and will subsequently influence the accuracy of the calculated DNA methylation by increasing the background. Poor conversion is particularly critical when MSPbased techniques, which detect methylation based on primer binding, are being used.
A potential PCR amplification bias [36, 37] towards either methylated or unmethylated templates further complicates DNA methylation ana lysis. The bias may apply to different extents for all methods utilizing methylation independent PCR primers (i.e. PCR primers that do not contain CpG sites). The inclusion of a limited number of CpG sites at the 5´-end of the primers allows the use of temperature dependent selection for methylated sequences to compensate for the PCR bias to unmethylated sequences [38] . n Outline of methodologies After PCR amplification of bisulfite modified DNA, a methylated CpG dinucleotide remains as a CpG, whereas an unmethylated CpG becomes a TpG. The different methylation assessment techniques then take advantage of this difference.
There are four broad groups of approaches depending on the type of primers and the type of ana lysis (Figure 2 ). The first group uses primers that are specific for the methylation status of the template, whereas the other groups use methylation independent primers that are intended to amplify the bisulfite modified DNA irrespective of its former methylation status.
The first group comprises methods that specifically amplify sequences based on their DNA methylation status (Figure 2A ). It includes MSP and its quantitative offshoots, including MethyLight and sensitive melting analysis after real time-MSP (SMART-MSP).
The second group comprises scanning methods that differentiate methylated, partially methylated and unmethylated sequences on the basis of their different physicochemical properties ( Figure 2B ). Single-strand conformation ana lysis utilizes the different single strand conformations formed by sequences of slightly or markedly different base compositions, whereas denaturing HPLC, denaturing gradient gel electrophoresis and high-resolution melting (HRM) measure the melting behavior of DNA duplexes.
The third group comprises of methodologies that investigate the methylation level of one or more CpG sites in a particular PCR product using a sequence dependent approach (direct bisulfite sequencing, bisulfite pyrosequencing, mass spectrometric approaches, methylation sensitive-single nucleotide primer extension [MS-SNuPE] and combined bisulfite restriction ana lysis [COBRA]). The DNA methylation level for a given CpG site is displayed as an average of its methylation over all the different epialleles amplified during PCR ( Figure 2C ).
The final group of approaches examines the methylation of individual PCR products ( Figure 2D ), either cloned from PCR products or digitally generated from single templates, most commonly by using sequencing or HRM-based methodologies. The investigation of multiple DNA methylation patterns can be used to generate a DNA methylation pattern profile for a PCR product mixture if desired, but is more useful for the ana lysis of the complexity of methylation patterns and for the quantification of methylated epialleles. n Bisulfite sequencing of clones (bisulfite genomic sequencing) This belongs to the final group of approaches, but as sequencing of individual clones was the first PCR-based methodology for the ana lysis of bisulfite modified DNA and remains a de facto gold standard, it is appropriate to begin with the consideration of this methodology. The amplicons generated during PCR amplification are cloned and individual clones are analyzed by Sanger sequencing [39] . Each CpG position of a single PCR amplicon of a single clone provides a binary answer; the CpG position is either methylated or unmethylated. Each clone gives the methylation pattern of a single epiallele.
The ana lysis of many clones provides detailed information to characterize the heterogeneity of a sample. Furthermore, this approach allows the quantification of individual epialleles as well as for each CpG position among the epialleles. The data ana lysis can be assisted by the appropriate software tools [40, 41] .
It is a vexed question as to how many individual clones need to be analyzed to provide a comprehensive overview of a sample with Readout using methylation-specific primers:
Overall readout across entire amplicon:
Average reading at each CpG position:
Individual reading of epialleles: Heterogeneous DNA methylation Review heterogeneous DNA methylation. Sequencing of clones is expensive and labor intensive. As the cost is dependent on the number of clones analyzed, usually less than 20 clones are sequenced per sample. In most cases this will be insufficient, as heterogeneously methylated samples are usually complex in nature. The information obtained therefore is accordingly compromised by stochastic effects. It should also be noted that the clones are derived from amplified PCR products and thus any PCR bias will be reflected in the clonal population. n Methods determining individual CpG methylation levels in PCR products These methods determine the DNA methylation level at each CpG position of the totality of the PCR products generated during PCR amplification. Direct bisulfite sequencing, bisulfite pyrosequencing and MassARRAY ® (EpiTYPER ® ) (Sequenom ® , CA, USA) of PCR products allow the estimation of DNA methylation levels as an average for each CpG position. COBRA and MS-SNuPE examine a more limited range of CpG sites. These methods may indicate methylation homogeneity or heterogeneity when individual CpGs are methylated to different extents, but do not provide single allele resolution. As a consequence, the fraction of methylated epialleles is underestimated when heterogeneous methylation is present, as the methylation frequency at each CpG site is less than the frequency of methylated epialleles (Figure 1 ).
Direct bisulfite sequencing
Direct bisulfite sequencing of PCR products allows the semiquantitative to quantitative estimation of DNA methylation level as an average for each CpG position [39, 42] . The DNA methylation level is calculated from the base proportions represented by different fluorescent dye signals in Sanger sequencing by capillary electrophoresis. It also allows ready detection and quantification of incomplete conversion by the examination of residual cytosines at the non-CpG cytosine positions.
When a mixture of unmethylated and fully methylated templates or a heterogeneously methylated sample is subjected to direct bisulfite sequencing, the four-dye electropherograms may show an increasingly poor peak quality with increasing nucleotide number, which usually complicates quantitative ana lysis because of the sequence-dependent differences in mobility of the different amplicons [43] . Finally, the peaks may get so broad that they tend to split. As a consequence, the four-dye electropherogram is a result of the overlapping and interfering individual electropherograms of the unmethylated and fully methylated epialleles or the heterogeneously methylated epiallele subpopulations.
By contrast, direct bisulfite sequencing of fully methylated or unmethylated amplicons results in a relatively clean four-dye electropherogram, therefore delivering a reliable nucleotide sequence and clear information about the DNA methylation level.
It must also be taken into account that the different fluorescent dyes of the labeled dideoxy terminator nucleotides (ddCTP/ddTTP for the sense strand and ddGTP/ddATP for the antisense strand) show different quantum efficiencies, resulting in different relative peak heights [43] . A sequence specific context and different efficiencies for the terminator incorporation may further cause peak heights different from the theoretical ratio.
An adaptation that addresses this issue and allows greater sensitivity (~10%) uses the sequencing of only C/T bases in the sense strand or A/G bases in the antisense strand. This approach improves the resolution of fluorescent peaks generated during gel separation, removing idiosyncrasies introduced when using multiple fluorescent dyes [44] .
The detection limit of sequence variants by Sanger sequencing is approximately 10-20% of variant bases [45] [46] [47] . A similar detection limit has been reported for methylated bases [44, 48] . For heterogeneously methylated amplicons, one would expect sequencing to underestimate the fraction of epialleles. The resulting electropherogram is mainly a result of the predominant epialleles and, due to averaging, the total amount of DNA methylation is therefore underestimated.
Bisulfite pyrosequencing
Bisulfite pyrosequencing is a sequencing-by-synthesis technique that has become increasingly popular for the ana lysis of DNA methylation as it provides relatively accurate quantification of methylation at individual CpG positions in a cost-effective manner [49] [50] [51] . The DNA methylation ratio is calculated from the signals observed for the two incorporated nucleotides, which determines the methylation status of a CpG position in a strand dependent manner (e.g., C/T on the sense strand and G/A on the antisense strand).
Bisulfite pyrosequencing is to some extent similar to direct bisulfite sequencing, but as it is not a mobility based method, the presence of future science group Review Mikeska, Candiloro & Dobrovic heterogeneous DNA methylation does not cause loss-of-phase of the sequencing information. Also the quantification of the DNA methylation level is more accurate. Finally, the detection limit at each CpG position is about 5% [52, 53] , and is therefore more sensitive than the detection limit of approximately 10-20% for direct bisulfite sequencing. This remains less sensitive than optimally desired for a biomarker.
Bisulfite pyrosequencing is somewhat disadvantaged by the relatively shorter length of sequence that can normally be analyzed (~100 bp [54, 55] ), but in many cases this is more than compensated by its ability to read cleanly at the beginning of a sequence, which is of paramount importance when short fragments are being analyzed, such as is recommended when analyzing DNA from formalin-fixed paraffin-embedded tissues.
While it has been claimed that bisulfite pyrosequencing is suitable for the ana lysis of heterogeneous methylation because of its more accurate quantification [54] , the quantitative results for the consecutive CpG positions analyzed reflect the average methylation level per CpG position. Thus, although heterogeneous DNA methylation can often be identified, the fraction of heterogeneously methylated epialleles cannot be quantified.
DNA methylation ana lysis via mass spectrometry
The commonly used mass spectrometry methodology is Sequenom MassARR AY (EpiTYPER). This method is based on base specific cleavage of single stranded RNA from amplicons generated during PCR amplification of bisulfite treated DNA. The mass of the resulting fragments is dependent on the methylation status of the amplicon's CpG dinucleotides. The cleavage products are detected by matrixassisted laser desorption ionization time-of-flight (MALDI-TOF) mass spectrometry [56] .
The methylation ratio for a single CpG position or a CpG unit is calculated from the signal intensities of the resultant cleavage products. The redundancy of certain cleavage products allows cross validation and the reliable determination of methylation levels [56] . DNA methylation levels are presented as a (semi)-quantitative result for a single CpG, or for multiple CpG positions, as an average of all PCR products generated during PCR amplification.
The MassARRAY approach delivers similar results to direct bisulfite sequencing but with a higher DNA methylation detection sensitivity.
The sensitivity is similar to that of bisulfite pyrosequencing but the length of sequence analyzed can be much greater [57] . Nevertheless, the coverage of CpGs within the PCR product analyzed is somewhat restricted owing to the inability to differentiate the masses of certain cleaved products. Some cleavage products may also contain multiple CpGs (as many as six or seven), which are then unable to be resolved. Usually, up to 80% of all CpG positions of an amplicon can be interrogated within a single cleavage reaction, delivering a DNA methylation profile that is near complete [56] .
MS-SNuPE
Methylation sensitive-single nucleotide primer extension is an adaptation of the single-nucleotide primer extension assay, which was originally introduced to type SNPs [58] . It is used to quantify the relative levels of cytosine and thymine at single CpG sites, essentially treating CpG sites as SNPs. Primer extension is performed on an aliquot of a PCR product generated from bisulfite treated DNA. The primer is placed immediately adjacent to the C of a CpG position. When the primer is extended, the inserted nucleotide depends on the DNA methylation present at that particular CpG position on the template. The calculated ratio is an average DNA methylation value at the CpG position of all different PCR products present. The DNA methylation ratio is quantitative and can be calculated by different detection systems utilizing radioactivity [59, 60] , peak heights in a chromatogram [61] or fluorescence [62] .
A major constraint of this approach is the limited access to certain CpG sites of the PCR product. The typical high CpG density of many regions limits the positions for an appropriate extension primer design, which should preferably bind regardless of methylation status. MS-SNuPE may be multiplexed [59, 61, 62] , but this approach is rarely used. A multiplex primer extension reaction is often not feasible, which limits the investigation of DNA methylation to a single CpG position. When only a single CpG dinucleotide is investigated, the determination of heterogeneity of DNA methylation is not possible and the overall methylation can be underestimated.
COBRA
Combined bisulfite restriction ana lysis is based on digestion with certain restriction endonucleases of the amplicons present after PCR amplification of bisulfite treated genomic DNA [63] . The digestion reaction is separated by gel electrophoresis and the restriction patterns allow an estimation or calculation of the DNA methylation level of one or future science group Heterogeneous DNA methylation Review more CpG position(s) as an average of the different PCR products generated during amplification. Depending on the restriction endonuclease and the monitoring system used, the digestion pattern delivers qualitative to semiquantitative results.
The limited number of cutting sites for a particular restriction endonuclease in an amplicon allows the ana lysis of one or a few CpG positions, which provides a limited overview of the DNA methylation profile and pattern present in a sample. This problem can be partly solved by using several restriction endonucleases, but this approach is limited by the relatively large amounts of PCR product required per enzyme. Although methylation heterogeneity for different CpG sites recognized by the same restriction endonuclease can be observed, quantification is limited.
The estimated methylation at a given CpG position is dependent on the cutting efficiency of the restriction endonuclease chosen. This can be highly dependent on the sequence context. An impaired cutting efficiency will lead to an underestimation of the DNA methylation level.
A further complication pertinent to heterogeneous products is the formation of heteroduplexes within the PCR products. As the restriction endonuclease examines both strands of DNA, heteroduplexes result in lower efficiencies, and therefore underestimation of DNA methylation [64] . n Methylation sensitive HRM In methylation sensitive-HRM (MS-HRM), the detection of DNA methylation is based on the use of a fully saturating double stranded DNA binding dye to monitor the different melting profiles derived from different samples and appropriate controls after PCR amplification of bisulfite treated DNA [65] . Methylated epialleles melt later than unmethylated epialleles as a consequence of the greater number of hydrogen bonds in CpG dinucleotides compared with TpG dinucleotides.
Methylation sensitive-HRM is an adaptation of the earlier melting curve methodology [66] . The melting profile of a sample is compared with melting profiles of controls where the methylation level is known. Homogeneous and heterogeneous DNA methylation can be distinguished by their characteristic melting profiles. MS-HRM has effectively replaced earlier but now rarely used DNA methylation scanning methodologies, such as single-strand conformation analysis [67] , denaturing HPLC [68, 69] and bisulfite denaturing gradient gel electrophoresis [18] .
With MS-HRM, the DNA methylation level of a homogeneously methylated sample can be estimated in a semiquantitative to quantitative manner and the detection limit can be in the range of 0.1-1% [70] . However, the presence of heterogeneous DNA methylation results in a complex melting profile that does not allow the ready estimation of the amount of methylated epialleles; the result is largely qualitative. n Methylation-specific PCR Methylation-specific PCR was the first of the nonsequencing bisulfite-based methods and remains a widely used DNA methylation analysis method. In its original form, two PCR reactions with primer pairs specific for fully methylated and unmethylated sequences were used for the amplification of bisulfite-treated genomic DNA, and the PCR products were analyzed by gel electrophoresis [71] .
Currently, it is common for only methylation specific primers to be used. The result obtained is qualitative and the band intensity of the reactions cannot be used to estimate the amount of methylated alleles. However, as the method is nonquantitative, even low background levels of DNA methylation may give a positive result. Due to this and other potential traps (reviewed in [72, 73] ), the results of this easily performed test should be interpreted with caution. In particular, incomplete conversion will increase the risk of false-positive results.
Whereas, with fully methylated and unmethylated templates, it is desirable to run MSP under highly stringent conditions to select against incompletely converted templates, this will also select against templates that are partially methylated in the primer recognition sequences. n MethyLight MethyLight is the name commonly given to quantitative ana lysis of DNA methylation using a TaqMan ® (Applied Biosystems, CA, USA) fluorescent probe to measure amplification in real-time. The most common procedure for MethyLight is based on MSP and utilizes methylation specific primers in combination with an internal methylation specific TaqMan fluorescent probe, and we will refer specifically to this version in the subsequent text [74] [75] [76] . The probe not only makes MSP quantitative by allowing real-time ana lysis but also reduces the risk of false-positive results due to incomplete conversion, as it generally contains one or more additional CpG sites.
When analyzing a homogeneously methylated sample, the estimation of the DNA methylation level by MethyLight is highly quantitative. However, heterogeneous DNA methylation will influence the annealing of both the primers and the probe in different and complex ways and the result will be at best only semiquantitative. Furthermore, the probe adds a strong bias towards the detection of fully methylated templates.
It was estimated that methylation can be detected by MethyLight in a 10,000-fold excess of unmethylated epialleles [76] . Nevertheless, heterogeneous methylation patterns will hamper any true quantification and reduce the sensitivity. Such sensitivities also require the input of a sufficient amount of bisulfite modified DNA.
A digital (PCR amplification from single templates) version of MethyLight has been developed using limiting dilution of templates [77] . This counting based approach retains some of the disadvantages of MethyLight for the ana lysis of heterogeneously methylated DNA, whereas PCR bias per se is not an issue, there may be partially methylated templates that either do not amplify or are not detected by the probe. Moreover, individual epialleles are not distinguished they are either amplified or not amplified.
More recently, fluorescent dyes have been used to monitor PCR amplification in real-time [78] . Most of these methods use SYBR ® Green (Applied Biosystems, CA, USA) as the fluorescent dye, but SMART-MSP [73] uses a fully saturating double stranded DNA binding fluorescent dye, which not only allows real-time ana lysis but also enables investigation of the MSP product by HRM. Fluorescent approaches are quantitative when dealing with homogeneously methylated sequences and when normalized relative to a control assay. They do not use a probe and thus the initial PCR needs very careful optimization. SMART-MSP is quality controlled via a post-PCR HRM ana lysis. If the stringency of the primer annealing is lowered, it can be used to amplify heterogeneously methylated templates, but as with MSP, care is needed not to amplify false-positives at the same time. In some cases, the false-positives can be recognized by HRM.
DNA methylation as a cancer biomarker n The optimal cancer biomarkers Currently, the best cancer biomarkers are those that are not methylated in normal healthy tissues and are relatively homogeneously methylated both at early stages and as the tumor progresses.
A thorough study for each cancer biomarker in normal tissues, particularly in peripheral blood, from a series of normal individuals needs to be performed. Furthermore, the biomarkers should be studied in both tumor and adjacent normal tissues in their target cancers.
Heterogeneous DNA methylation patterns introduce particularly difficult problems when investigating low level DNA methylation. This is an important consideration when heterogeneously methylated regions are used as biomarkers for detection of early and minimal residual disease.
Some DNA methylation biomarkers have already been adopted as disease markers in various studies. DNA methylation of MLH1 and BRCA1 in normal tissues indicates a predisposition to the development of colorectal and breast cancer, respectively [79, 80] . CDKN2A (p16) in sputum has been used to screen patients at increased risk of lung cancer [81] and GSTP1 is an exceptionally clean biomarker for early detection of prostate cancer [82] . n Digital PCR approaches enable the use of heterogeneously methylated biomarkers If homogeneously methylated biomarkers are available, all the methodologies discussed are capable of producing useful quantitative results, except for the nonquantitative MSP approaches. However, the current and probably future paucity of consistently homogeneously methylated biomarkers means that hetero geneously methylated biomarkers usually need to be used, for example, CDKN2B in myelodysplasia [54] . Whereas averaging methodologies provide some information as to whether a locus is methylated (Figure 2C ), only digital methodologies that provide information regarding individual epialleles are really adequate for accurate quantification. With digital methodologies, all methylated genes that are unmethylated in control tissues become of potential utility as epigenetic biomarkers.
Digital PCR was first used to detect somatic mutations present in genomic DNA [83] . The digital approach has now been applied for DNA methylation ana lysis and allows the ana lysis of single template epialleles, eliminating the potential PCR amplification bias seen in bisulfite sequencing of single clones that are cloned from PCR products rather than individual templates [22, 43, 77, 80] .
Digital PCR depends on limiting dilution. The templates in the sample to be investigated are diluted to the point where the majority of wells future science group Heterogeneous DNA methylation Review contain either no template or only a single template copy according to the Poisson distribution. Methylation-independent bisulfite-specific primers are used to allow the amplification of each different epiallele regardless of its DNA methylation status. PCR is performed on single molecules, therefore generating a homo geneous amplicon population in each well or tube. Positive amplification is detected by a variety of methods and these wells can subsequently be sequenced [43, 77] .
All the methods described in the section titled 'Methods determining individual CpG methylation levels in PCR products' can be used for ana lysis of epialleles cloned by digital PCR. Sanger sequencing is most commonly used but pyrosequencing and perhaps MassARRAY (EpiTYPER) are likely to be used in the future.
The question of how many individual epialleles need to be analyzed to provide a comprehensive map of a sample with heterogeneous DNA methylation patterns, that we previously raised for bisulfite sequencing of cloned PCR products applies for these approaches also. The problem with sequencing all the digital clones is that, like bisulfite sequencing of cloned PCR products, the costs of sequencing may be too high to generate sufficient data for a comprehensive ana lysis, especially when a considerable fraction of epialleles may be unmethylated.
Digita l methylation-sensitive HR M (dMS-HRM) screening, where the PCR amplification of a limiting dilution of templates is followed by HRM ana lysis, is a versatile digital approach [22, 80] . HRM will distinguish PCR amplification positive wells from primer dimers, and can simultaneously not only count the methylated alleles but also assess the extent of DNA methylation of each epiallele (Figure 3) . Only methylated epialleles need to be sequenced if the patterns of DNA methylation need to be analyzed. In addition, melting profiles that do not meet the quality control criteria (e.g., more than one template present in one reaction well) can easily be identified by the shape of the melting profile and discarded prior to ana lysis.
An emergent digital methodology is methylBEAMing (where BEAM stands for beads, emulsion, amplification and magnetics) [84] . The amplification occurs in microdroplets in an emulsion, the subsequent ana lysis of the PCR amplicons trapped on beads is by probes corresponding to fully methylated and unmethylated amplicons. Although these probes may cross hybridize to partially methylated amplicons, so far the methodology has not been adapted for comprehensive ana lysis of heterogeneously methylated epialleles. Figure 3 . Digital methylation-sensitive high-resolution melting ana lysis of the CDKN2B (p15) gene. (A) Methylation-sensitive high-resolution melting (MS-HRM) melting profile for an acute myeloid leukemia (AML) sample compared with fully methylated and unmethylated controls. Due to the formation of heteroduplexes between closely related epialleles, MS-HRM cannot quantify heterogeneous DNA methylation but can identify it due to the absence of specific methylated and/or unmethylated peaks. In this case, the profile extends into the region of the fully methylated control without actually forming a distinct methylated peak. (B) Digital MS-HRM is able to reveal the nature of DNA methylation present. The spectrum of methylation in this case is weighted towards the more heavily methylated epialleles. Using digital MS-HRM to clone templates avoids PCR bias and can serve as a prescreening process before selecting 'clones' for sequencing. (C) Representation of the sequence of selected 'clones' using green and blue circles to indicate unmethylated and methylated CpG sites, respectively. Representatives of increasingly more methylated epialleles are shown. The letters A-F correspond with the melting profiles shown in (B) from which they derive. Sequencing reveals the exact DNA methylation pattern for each cloned epiallele. Adapted from [22] .
future science group Review Mikeska, Candiloro & Dobrovic sequencing of PCR amplicons. It is directly analogous to bisulfite sequencing of single clones except that the 'cloning' of the PCR product is carried out by limiting dilution in an emulsion. It must be noted that this is intrinsically different from limiting dilution of templates prior to PCR amplification as used in digital MS-HRM, as PCR bias may still occur and lead to selective representation of epialleles.
The first report of this technology used pooled PCR products to analyze multiple amplicons in leukemia and lymphoma samples [85] . Massively parallel sequencing has subsequently been used to analyze the methylation of candidate biomarkers in breast cancer [86] and of the MLH1 gene promoter in endometrial cancer [23] . These publications revealed heterogeneous patterns of methylation at the promoters of these genes that would have been difficult to detect by any other methodology, and confirmed that heterogeneous methylation is not only a technical problem but also an interesting phenomenon worthy of further study in order to increase our overall understanding of DNA methylation.
Conclusion
If heterogeneous DNA methylation is not taken into account, the correct interpretation of methylation data will be compromised, in particular in any instance where quantification is of importance. In this article, we have shown that different methodologies which can be fairly unanimous in the detection and quantification of fully methylated templates can lead to divergent results when heterogeneously methylated samples are analyzed.
Heterogeneous DNA methylation cannot be fully characterized without a method that allows the direct visualization of individual clones. Only in such cases can the entire population of heterogeneously methylated epialleles be quantified. The best current solution is a limiting dilution digital approach. The use of single templates allows amplification without PCR bias. Furthermore, subsequent DNA sequencing allows the detection of templates with a poor bisulfite conversion, which then can be excluded from the ana lysis.
Future perspective
The main impediment to the adoption of digital approaches is the expense of performing multiple PCR reactions. As the technologies improve to allow the ana lysis of multiple replicates in a cost-effective manner, digital ana lysis will become more routine and enable the adoption of heterogeneously methylated regions as cancer biomarkers.
Costs will come down owing to increasing miniaturization of the reaction vessels and consequent reduction in the amount of reagent needed. The use of nanodrops of liquid in an emulsion as reaction vessels, as has been used for methyl-BEAMing and for massively parallel sequencing, is likely to become more common.
Executive summary

Introduction
DNA methylation is often heterogeneous. Heterogeneous methylation makes the fraction of methylated alleles difficult to adequately quantify. This compromises its use as a biomarker.
Methods
There are many methodologies used to examine locus specific DNA methylation. Most of these methodologies have limitations when it is desired to use a heterogeneously methylated region as an epigenetic biomarker.
DNA methylation as a cancer biomarker
Currently, the optimal epigenetic biomarkers are those where the normal state is unmethylated, and the disease state is completely methylated. In this case, several existing methodologies can adequately quantify the level of methylation. Digital methodologies using limiting dilution of templates most accurately quantify individual epialleles when heterogeneous methylation is present. Digital methylation-sensitive high resolution melting can accurately represent the extent of DNA methylation. It can reduce the cost of sequencing by indicating clearly unmethylated alleles. Massively parallel sequencing of PCR products from bisulfite modified DNA displays heterogeneous methylation based on multiple epialleles but suffers from a potential PCR bias.
Conclusion
An understanding of heterogeneous methylation is vital for the use of DNA methylation as a cancer biomarker. Digital approaches counting individual epialleles will yield the most informative results.
Future perspective
The optimal approach for quantification of DNA methylation at an allelic level will be based on a high-throughput approach that avoids PCR bias by assessing individual methylated templates. 
